Miral, Silverio C.

HRN: 04-04-88  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2022
CEFTRIAXONE 1G (VIAL)
11/09/2022
11/15/2022
IV
2gms
Od
Uti, Bibasal Pneumonia
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes